HB 1741Washington

Expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.

In committee

Jan 12, 2026: By resolution, reintroduced and retained in present status.

Follow this bill Ratifi